Precigen (PGEN) Interest Coverage Ratio (2012 - 2026)
Precigen (PGEN) reported Interest Coverage Ratio of 2.06 for Q1 2026, up 99.99% year-over-year from 1.03 in Q1 2025, and up 71.8% quarter-over-quarter from 7.31 in Q4 2025.
Precigen (PGEN) Interest Coverage Ratio (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Interest Coverage Ratio data on file, last reported at 2.06 in Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 2.06, up 99.99% year-over-year; the trailing twelve-month figure through Mar 2026 was 13.86 (up 99.95% YoY), and the FY2025 annual result was 28.58, up 99.87% from the prior year.
- Interest Coverage Ratio rose to 2.06 in Q1 2026 per PGEN's latest filing, from 7.31 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 2.06 in Q1 2026 and troughed at 30420.5 in Q2 2024.
- A 5-year average of 6800.97 and a median of 72.46 in 2023 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2026: Interest Coverage Ratio plunged 559759.89% in 2023, then soared 99.99% in 2026.
- A 5-year view of Interest Coverage Ratio shows it stood at 34.22 in 2022, then sank by 14188.13% to 4889.14 in 2023, then plunged by 117.44% to 10631.0 in 2024, then surged by 99.93% to 7.31 in 2025, then jumped by 71.8% to 2.06 in 2026.
- Business Quant data shows PGEN's Interest Coverage Ratio at 2.06 in Q1 2026, 7.31 in Q4 2025, and 38.23 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | -2.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.06 |
| Dec 31, 2025 | -7.31 |
| Sep 30, 2025 | -38.23 |
| Mar 31, 2025 | -22,596.00 |
| Sep 30, 2024 | -10,631.00 |
| Jun 30, 2024 | -30,420.50 |
| Mar 31, 2024 | -12,205.00 |
| Dec 31, 2023 | -4,889.14 |
| Sep 30, 2023 | -20,937.00 |
| Jun 30, 2023 | -155.29 |
| Mar 31, 2023 | -72.46 |
| Dec 31, 2022 | -34.22 |
| Sep 30, 2022 | -3.74 |
| Jun 30, 2022 | -11.71 |
| Mar 31, 2022 | -10.87 |
| Dec 31, 2021 | -4.51 |
| Sep 30, 2021 | -4.52 |
| Jun 30, 2021 | -5.66 |
| Mar 31, 2021 | -3.90 |
| Dec 31, 2020 | -2.00 |